Webcast - Molecular Characterization and Therapeutic Management of Prostate Cancer

"Webcast - Molecular Characterization and Therapeutic Management of Prostate Cancer" - is a virtual recorded lecture series from our online conference on May 8th, 2021. 

The clinical management of metastatic prostate cancer is improving at a rapid pace, increasingly influenced by the advancement in molecular characterization of this disease. In particular, the identification of driver mutations and delineation of the molecular signatures of have resulted in significant improvements in the array of treatment options for this disease and improved individualization of prognosis. There are still uncertainties regarding the management of early prostate cancer. This meeting will provide an opportunity to hear from leading national and international experts on how recently published data may change practice, some of which will have immediate clinical applications. Furthermore, each session will have multiple segments on novel emerging treatment paradigms likely to transform the care of metastatic prostate cancer in the near future.

This virtual conference is intended to propagate new information to augment the knowledge and clinical competence of the cancer care providers in the following areas:

  • Advances in the identification of molecular driver mutations that impact prognosis for patients with Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Use of molecular treatments in metastatic prostate cancer
  • Discussion of immediate versus delayed systemic therapy for patients with biochemical (PSA) failure after definitive, local treatment
  • Role of molecular imaging (PET based imaging) to clarify staging

Target Audience

  • Oncologists
  • Residents/Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Explain the nuances of the data regarding optimal timing of initiation of androgen deprivation therapy (ADT) for patients with biochemical failure
  • Review recent data on the use of genomic testing to define the prognosis of patients with mCSPC
  • Summarize genomic testing to select treatment for metastatic castration-resistant prostate cancer
  • Discuss the optimal use of molecular imaging tests
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 2.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.00 Contact Hours.
Course opens: 
05/09/2021
Course expires: 
05/07/2022
Cost:
$1.00

This educational activity features recorded videos from the live virtual meeting held on 5/8/21. The videos are placed in the following order. Feel free to view the content that is relevant to you. Participants should claim continuing education credits to the extent of their participation.

 

30 min - The role of molecular imaging (PET) as a diagnostic tool in prostate cancer – Dr. Tanya Dorff

30 min - Systemic therapy in biochemical recurrence – Dr. Benjamin L. Maughan

30 min - Updates in cellular and molecular testing to define prognosis and personalized therapy – Dr. Umang Swami

30 min - Novel immune therapy approaches for metastatic prostate cancer: advances in systemic therapy – Dr. Ulka Vaishampayan

 

 

BENJAMIN MAUGHAN, MD, PHARMD

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

ULKA VAISHAMPAYAN, MD, 

Professor of Medicine

University of Michigan

Learn More

UMANG SWAMI, MD

Assistant Professor of Medicine

Huntsman Cancer Institute, University of Utah

Learn More

TANYA DORFF, MD

Associate Clinical Professor of Medicine

City of Hope

Learn More

Disclosure of Conflict of Interest:

No Members of this activity's planning committee or faculty have any relevant financial relationship with an ineligible entity with the exception of the following faculties:

  • Ulka Vaishampayan, M.D. :Research Support - BMS, Merck and Astellas Inc, Consulting and Honoraria - from BMS, Bayer, Pfizer, Merck, AAA, Alkermes and Exelixis

All relevant financial relationships of individuals in control of the content have been identified and mitigated.  

DISCUSSION OF OFF LABEL PRODUCTS:

If any part of this activity will include the discussion of unapproved or investigational products, faculty discussing those products will clearly identify the product as investigational or not approved. 

  • Umang SwamiI, M.D.: Only peer reviewed literature with regards to cellular or molecular testing.
  • Tanya Dorff, M.D.: Lu177-PSMA

Important Information about Claiming CME for this activity:

If you participated in our live webinar on 5/8/2021 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that webinar on 5/8/2021. 


The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 2.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.00 Contact Hours.

ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 2.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 2.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 2.00 Contact Hours.

Price

Cost:
$1.00
Please login or register to take this course.

Registration Fees:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($200 + 3% Credit card fee) 

 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, please register for the course here

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant. Sign up for this activity as an industry representative here. If you paid to join the live meeting and wish to register for this enduring material please contact us and we will register you for free.

 

Cancellation Policy

You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, watching the recorded content, and completion of pre & post tests as well as course evaluations.

 

Refund Policy 

This activity is free for all healthcare providers who are not employees of an ineligible entity.

No refunds will be issued if you have started watching the recorded content.